Conditions: Meniscectomy
Keywords: Knee Arthroscopy
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 112
Healthy volunteers: yes

Brief summary:
Ketorolac is administered as current practice to the majority of patients undergoing knee arthroscopy, the appropriate dose of ketorolac to be administered has not been evaluated.

Detailed description:
Past studies have examined different doses of ketorolac administered to patients after spinal fusion surgery and found that 7.5 mg every 6 hours was as effective as 15 or 30 mg every 6 hours in decreasing postoperative pain and patient opiate consumption. Since ketorolac side effects such as gastrointestinal and surgical site bleeding seem to be dose related, utilizing a lower dose of ketorolac may be more efficacious.

Arms:
arm 1: participant receives 0 mg of Ketorolac arm 2: participant receives 7.5 mg of Ketorolac arm 3: participant receives 15 mg of Ketorolac arm 4: participant receives 30mg of Ketorolac

Interventions: intervention 1: Ketorolac Dose
Intervention descriptions: intervention 1: Subjects will be assigned an enrollment number. Enrollment numbers will be assigned consecutively in the order of study enrollment. Based on the enrollment number, subjects will be randomized by a pre-determined computer randomization list created by a statistician to receive a ketorolac dose (0, 7.5, 15, 30 mg).

Protocol document: